Cobb Stuart

Chief Scientific OfficerNeurogene Inc. (NGNE) · full profile →Form 4 · filed Mar 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$141K
Net Open-Market Flow
-$141K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2026Sell(S)3K$21.34$57K31K
Mar 13, 2026Sell(S)4K$20.41$81K33K
Mar 13, 2026Sell(S)148$22.08$3K30K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001994301-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: